Literature DB >> 25584218

Comparison Between Virulence Factors of Candida albicans and Non-Albicans Species of Candida Isolated from Genitourinary Tract.

Shani Jacob1, Diney D'Souza1.   

Abstract

BACKGROUND: Candida spp. is frequently isolated from cases of vulvovaginal candidiasis and catheter associated UTI. C.albicans is the most frequently isolated species but non-albicans species of candida are gaining clinical significance.
OBJECTIVES: To compare the virulence factors like biofilm production, phospholipase and hemolytic activity in C.albicans with that of non albicans species of candida isolated from urogenital tract.
MATERIALS AND METHODS: Vaginal swabs and urine samples received in Microbiology laboratory during one year period were processed by standard methods. The candida isolates were speciated and biofilm production, phospholipase and hemolytic activity were studied in them. Statistical analysis was performed using SPSS version 11.5.
RESULTS: Out of the 3001 urine samples processed 41 (1.3%) were positive for candida, out of 293 high vaginal swabs 41(14%) were positive for candida. C.albicans was the most prevalent isolate followed by C.tropicalis, C.glabrata and C.krusei. Out of 40 C.albicans strains, 22 (55%) produced biofilm, 39 (97.5%) produced hemolysin and 21 (52.5%) produced phospholipase. Out of 42 strains of non albicans species of candida, 19 (45%) produced biofilm, 41(97.6%) hemolysin and 5 (12%) produced phospholipase.
CONCLUSION: Phospholipase production was better in C.albicans in comparison toother species of candida. There was no statistically relevant difference between hemolysin and biofilm production by C.albicans and non albicans strains of candida.

Entities:  

Keywords:  Biofilm production; Candida; Hemolytic activity; Phospholipase; Urogenital tract

Year:  2014        PMID: 25584218      PMCID: PMC4290236          DOI: 10.7860/JCDR/2014/10121.5137

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  9 in total

Review 1.  Candida species: current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options.

Authors:  J C O Sardi; L Scorzoni; T Bernardi; A M Fusco-Almeida; M J S Mendes Giannini
Journal:  J Med Microbiol       Date:  2012-11-22       Impact factor: 2.472

2.  Production of haemolytic factor by clinical isolates of Candida tropicalis.

Authors:  D Favero; E J G França; L Furlaneto-Maia; R M B Quesada; M C Furlaneto
Journal:  Mycoses       Date:  2011-06-14       Impact factor: 4.377

Review 3.  Candida infections of the genitourinary tract.

Authors:  Jacqueline M Achkar; Bettina C Fries
Journal:  Clin Microbiol Rev       Date:  2010-04       Impact factor: 26.132

4.  Phospholipase B enzyme expression is not associated with other virulence attributes in Candida albicans isolates from patients with human immunodeficiency virus infection.

Authors:  Y H Samaranayake; R S Dassanayake; J Ams Jayatilake; B Pk Cheung; J Yy Yau; K Ws Yeung; L P Samaranayake
Journal:  J Med Microbiol       Date:  2005-06       Impact factor: 2.472

5.  Candida dubliniensis does not show phospholipase activity: true or false?

Authors:  Liliane Alves Scheid; Débora Alves Nunes Mario; Paulo Guilherme Markus Lopes; Erico de Loreto; Carlos Eduardo Blanco Linares; Janio Morais Santurio; Sydney Hartz Alves
Journal:  Rev Soc Bras Med Trop       Date:  2010 Mar-Apr       Impact factor: 1.581

6.  Antifungal susceptibilities of Candida species causing vulvovaginitis and epidemiology of recurrent cases.

Authors:  Sandra S Richter; Rudolph P Galask; Shawn A Messer; Richard J Hollis; Daniel J Diekema; Michael A Pfaller
Journal:  J Clin Microbiol       Date:  2005-05       Impact factor: 5.948

7.  Investigating biofilm production, coagulase and hemolytic activity in Candida species isolated from denture stomatitis patients.

Authors:  Nimet Yigit; Esin Aktas; Saadettin Dagistan; Ahmet Ayyildiz
Journal:  Eurasian J Med       Date:  2011-04

Review 8.  Candida biofilms and their role in infection.

Authors:  L Julia Douglas
Journal:  Trends Microbiol       Date:  2003-01       Impact factor: 17.079

9.  Distribution of Candida species in different clinical samples and their virulence: biofilm formation, proteinase and phospholipase production: a study on hospitalized patients in southern India.

Authors:  Vinitha Mohandas; Mamatha Ballal
Journal:  J Glob Infect Dis       Date:  2011-01
  9 in total
  9 in total

1.  [Candiduria! What now? : Therapy of urinary tract infections with Candida].

Authors:  H Hof
Journal:  Urologe A       Date:  2017-02       Impact factor: 0.639

2.  Comparative Analysis of the Capacity of the Candida Species To Elicit Vaginal Immunopathology.

Authors:  Hubertine M E Willems; David J Lowes; Katherine S Barker; Glen E Palmer; Brian M Peters
Journal:  Infect Immun       Date:  2018-11-20       Impact factor: 3.441

3.  Virulence Factors and Antifungal Susceptibility Profile of C. tropicalis Isolated from Various Clinical Specimens in Alexandria, Egypt.

Authors:  Mohammed A El-Kholy; Ghada F Helaly; Ebtisam F El Ghazzawi; Gamal El-Sawaf; Sherine M Shawky
Journal:  J Fungi (Basel)       Date:  2021-04-29

4.  Evaluation of Virulence Factors In vitro, Resistance to Osmotic Stress and Antifungal Susceptibility of Candida tropicalis Isolated from the Coastal Environment of Northeast Brazil.

Authors:  Diana L Zuza-Alves; Sayama S T Q de Medeiros; Luanda B F C de Souza; Walicyranison P Silva-Rocha; Elaine C Francisco; Maria C B de Araújo; Reginaldo G Lima-Neto; Rejane P Neves; Analy S de Azevedo Melo; Guilherme M Chaves
Journal:  Front Microbiol       Date:  2016-11-15       Impact factor: 5.640

Review 5.  An Update on Candida tropicalis Based on Basic and Clinical Approaches.

Authors:  Diana L Zuza-Alves; Walicyranison P Silva-Rocha; Guilherme M Chaves
Journal:  Front Microbiol       Date:  2017-10-13       Impact factor: 5.640

6.  Relationship between the Antifungal Susceptibility Profile and the Production of Virulence-Related Hydrolytic Enzymes in Brazilian Clinical Strains of Candida glabrata.

Authors:  Maria Helena Galdino Figueiredo-Carvalho; Lívia de Souza Ramos; Leonardo Silva Barbedo; Jean Carlos Almeida de Oliveira; André Luis Souza Dos Santos; Rodrigo Almeida-Paes; Rosely Maria Zancopé-Oliveira
Journal:  Mediators Inflamm       Date:  2017-07-26       Impact factor: 4.711

7.  An Exaggerated Monocyte-Derived Cytokine Response to Candida Hyphae in Patients With Recurrent Vulvovaginal Candidiasis.

Authors:  Diletta Rosati; Mariolina Bruno; Martin Jaeger; Bart-Jan Kullberg; Frank van de Veerdonk; Mihai G Netea; Jaap Ten Oever
Journal:  J Infect Dis       Date:  2022-05-16       Impact factor: 7.759

8.  First description of Candida nivariensis in Brazil: antifungal susceptibility profile and potential virulence attributes.

Authors:  Maria Helena Galdino Figueiredo-Carvalho; Livia de Souza Ramos; Leonardo Silva Barbedo; Alessandra Leal da Silva Chaves; Ilda Akemi Muramoto; André Luis Souza dos Santos; Rodrigo Almeida-Paes; Rosely Maria Zancopé-Oliveira
Journal:  Mem Inst Oswaldo Cruz       Date:  2016-01       Impact factor: 2.743

9.  A Linear 19-Mer Plant Defensin-Derived Peptide Acts Synergistically with Caspofungin against Candida albicans Biofilms.

Authors:  Tanne L Cools; Caroline Struyfs; Jan W Drijfhout; Soňa Kucharíková; Celia Lobo Romero; Patrick Van Dijck; Marcelo H S Ramada; Carlos Bloch; Bruno P A Cammue; Karin Thevissen
Journal:  Front Microbiol       Date:  2017-10-20       Impact factor: 5.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.